91 related articles for article (PubMed ID: 25201479)
1. Subcellular mechanisms underlying digitalis-induced arrhythmias: role of calcium/calmodulin-dependent kinase II (CaMKII) in the transition from an inotropic to an arrhythmogenic effect.
Gonano LA; Petroff MV
Heart Lung Circ; 2014 Dec; 23(12):1118-24. PubMed ID: 25201479
[TBL] [Abstract][Full Text] [Related]
2. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias.
Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M
Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705
[TBL] [Abstract][Full Text] [Related]
3. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
[TBL] [Abstract][Full Text] [Related]
4. Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology.
Fischer TH; Herting J; Tirilomis T; Renner A; Neef S; Toischer K; Ellenberger D; Förster A; Schmitto JD; Gummert J; Schöndube FA; Hasenfuss G; Maier LS; Sossalla S
Circulation; 2013 Aug; 128(9):970-81. PubMed ID: 23877259
[TBL] [Abstract][Full Text] [Related]
5. Ryanodine receptor phosphorylation, calcium/calmodulin-dependent protein kinase II, and life-threatening ventricular arrhythmias.
McCauley MD; Wehrens XH
Trends Cardiovasc Med; 2011 Feb; 21(2):48-51. PubMed ID: 22578240
[TBL] [Abstract][Full Text] [Related]
6. Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides.
Ho HT; Liu B; Snyder JS; Lou Q; Brundage EA; Velez-Cortes F; Wang H; Ziolo MT; Anderson ME; Sen CK; Wehrens XH; Fedorov VV; Biesiadecki BJ; Hund TJ; Györke S
Cardiovasc Res; 2014 Jan; 101(1):165-74. PubMed ID: 24104877
[TBL] [Abstract][Full Text] [Related]
7. Sarcoplasmic reticulum calcium leak and cardiac arrhythmias.
Chelu MG; Wehrens XH
Biochem Soc Trans; 2007 Nov; 35(Pt 5):952-6. PubMed ID: 17956253
[TBL] [Abstract][Full Text] [Related]
8. On the differences between ouabain and digitalis glycosides.
Fuerstenwerth H
Am J Ther; 2014; 21(1):35-42. PubMed ID: 21642827
[TBL] [Abstract][Full Text] [Related]
9. Calcium/calmodulin-dependent protein kinase IIdelta associates with the ryanodine receptor complex and regulates channel function in rabbit heart.
Currie S; Loughrey CM; Craig MA; Smith GL
Biochem J; 2004 Jan; 377(Pt 2):357-66. PubMed ID: 14556649
[TBL] [Abstract][Full Text] [Related]
10. Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies.
George CH; Jundi H; Thomas NL; Fry DL; Lai FA
J Mol Cell Cardiol; 2007 Jan; 42(1):34-50. PubMed ID: 17081562
[TBL] [Abstract][Full Text] [Related]
11. Ca2+/Calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes.
Guo T; Zhang T; Mestril R; Bers DM
Circ Res; 2006 Aug; 99(4):398-406. PubMed ID: 16840718
[TBL] [Abstract][Full Text] [Related]
12. Oxidation- and CaMKII-mediated sarcoplasmic reticulum Ca(2+) leak triggers atrial fibrillation in aging.
Guo X; Yuan S; Liu Z; Fang Q
J Cardiovasc Electrophysiol; 2014 Jun; 25(6):645-52. PubMed ID: 24576293
[TBL] [Abstract][Full Text] [Related]
13. A knock-in mouse model of N-terminal R420W mutation of cardiac ryanodine receptor exhibits arrhythmogenesis with abnormal calcium dynamics in cardiomyocytes.
Okudaira N; Kuwahara M; Hirata Y; Oku Y; Nishio H
Biochem Biophys Res Commun; 2014 Sep; 452(3):665-8. PubMed ID: 25193700
[TBL] [Abstract][Full Text] [Related]
14. CaMKII as a target for arrhythmia suppression.
Mustroph J; Neef S; Maier LS
Pharmacol Ther; 2017 Aug; 176():22-31. PubMed ID: 27742568
[TBL] [Abstract][Full Text] [Related]
15. Role of CaMKII in post acidosis arrhythmias: a simulation study using a human myocyte model.
Lascano EC; Said M; Vittone L; Mattiazzi A; Mundiña-Weilenmann C; Negroni JA
J Mol Cell Cardiol; 2013 Jul; 60():172-83. PubMed ID: 23624090
[TBL] [Abstract][Full Text] [Related]
16. Arrhythmogenic mutation-linked defects in ryanodine receptor autoregulation reveal a novel mechanism of Ca2+ release channel dysfunction.
George CH; Jundi H; Walters N; Thomas NL; West RR; Lai FA
Circ Res; 2006 Jan; 98(1):88-97. PubMed ID: 16339485
[TBL] [Abstract][Full Text] [Related]
17. CaMKII and its role in cardiac arrhythmia.
Erickson JR; Anderson ME
J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1332-6. PubMed ID: 18803570
[TBL] [Abstract][Full Text] [Related]
18. The calcium/calmodulin/kinase system and arrhythmogenic afterdepolarizations in bradycardia-related acquired long-QT syndrome.
Qi X; Yeh YH; Chartier D; Xiao L; Tsuji Y; Brundel BJ; Kodama I; Nattel S
Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):295-304. PubMed ID: 19808480
[TBL] [Abstract][Full Text] [Related]
19. The Ca-calmodulin dependent kinase II: a promising target for future antiarrhythmic therapies?
Fischer TH; Neef S; Maier LS
J Mol Cell Cardiol; 2013 May; 58():182-7. PubMed ID: 23159442
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system.
Okatan EN; Tuncay E; Turan B
J Nutr Biochem; 2013 Dec; 24(12):2110-8. PubMed ID: 24183307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
